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Abstract  
Leishmaniasis is world-wide one of the most common infectious disorders caused by protozoa. Due to the climate 
change, there is a risk of further spread of the disease to central and northern Europe. Another important issue is 
the high number of refugees from Syria since Syria is one of the hot spots of Old World leishmaniasis. We report 
on single-centre experience with leishmaniasis in the capital of Saxony, Dresden, during the years 2001 to 2017. 
We noted a substantial increase in the last five years. Once a very rare exotic disorder in Germany, cutaneous 
leishmaniasis has become a reality and physicians should be aware of it. A significant number of cases are from 
Syrian refugees; other cases had been acquired by tourists in the Mediterranean region! 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
The climate change has the potential for 
distribution and epidemiology of skin diseases. In 
case of infectious dermatoses, climate may modulate 
the distribution of both, pathogens and vectors [1].  
Leishmaniasis is a protozoal disease with 
cutaneous, mucocutaneous and visceral subtypes. 
World-wide, about two million people are affected. 
Pathogens are Trypanosoma-like Leishmania with the 
major subgenera Leishmania and Viannia. Around 20 
species have been identified so far.  
Cutaneous leishmaniasis is classified into Old 
World- and New World- disease. Also, there is 
mucocutaneous and visceral leishmaniasis, also 
known as Kala-Azar [2]. 
The classical distribution of leishmaniasis is 
Central and South Americas, China, Sri Lanka, the 
Indian subcontinent, North, East, West and Central 
Africa, Middle East, and the Mediterranean. 
Transmission occurs by blood-sucking female insects 
of the genus Phlebotomus (Old World) and Lutzomyia 
(New World). Pathogen reservoir includes rodents, 
canine, feline, and humans. The incubation period 
may vary between some weeks and several months. 
The protozoa are located intracellular and modify the 
host response reactions immunologically [3]. 
Entomological investigations suggest changes 
in the geographical distribution of Leishmania vectors. 
An increased risk for vectors has been calculated for 
the European Atlantic coast, Austria, Germany, and 
Switzerland [4]. In Germany, there are two possible 
mosquito vectors, i.e. Phlebotomus  (P.) mascittii and 
P. pernicious [5]. In Northern Italy, Ixodes ricinus had 
been identified as another possible vector since 7.5% 
of all tick bites had a positive polymerase chain 
reaction (PCR) for Leishmania (L.) infantum [6]. PCR 
plus sequencing and/ or multiple restriction enzyme 
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digestions (RFLP) is now considered as gold standard 
in diagnosis [7].  
We report on cutaneous leishmaniasis cases, 
diagnosed and treated at our department during the 
years 2001 - July 2017.  
 
 
Patients and Methods 
 
This is a single-centre retrospective study 
using the patient files at the academic teaching 
hospital Dresden-Friedrichstadt from January 2001 to 
July 2017. All patients that could be identified by 
diagnosis of cutaneous leishmaniasis were included. 
 
 
Results 
 
We identified nine patients – 6 males and 
three females – with age between 1.5 years and 33 
years. Five patients were refugees from Aleppo, Syria 
(Table 1).  
Table 1: Cutaneous leishmaniasis 2001-17 (PR, partial 
remission; CR, complete remission) 
 
 
All cases were identified since 2013; there 
was not a single case before. The lesions developed 
up to 6 months before a diagnosis was confirmed. 
Major differential diagnoses were pyoderma and 
infected insect bites. The diagnosis was confirmed by 
histologic proof of intracellular amastigotes in eosin-
hematoxylin or Giemsa stains. Four cases occurred in 
a single family. Here, we decided to confirm clinical 
diagnosis in the oldest child only. In another infant, 
infected with Sicily, polymerase chain reaction (PCR) 
was performed at the Benhard-Nocht-Institute for 
Tropical Medicine, Hamburg.  PCR was positive for 
Leishmania spp., sequencing excluded L. braziliensis 
and L. major complex but confirmed L. donovani 
complex. Eventually, L. infantum infection could be 
belayed. Other infections were acquired during 
holidays in Northern Italy and Crete, Greece. 
 
Figure 1: Clinical presentations of Old World cutaneous 
leishmaniasis. (a) Plaques; (b) Atrophic plaques; (c) Plaque with 
elevated borders; (d) Ulcerated plaque with eschar; (e) Firm nodule; 
(f) Abscess-like nodule; (g) Erosive plaques; (h) Verrucous plaque; 
(i) Eczematous lesions 
 
We used pentavalent antimonials 
(Glucantime) (n = 5), meglumine stibnite (n = 1), azole 
derivates (n = 2) or paromomycin ointment (n = 1) to 
treat our patients. Eight patients achieved a complete 
remission (CR), one achieved a partial remission 
(PR). In the latter two cases, treatment is continued. 
Treatment was well tolerated. To reduce the injection-
associated pain, topical lidocaine/prilocaine ointment 
(EMLA® cream) was applied. We observed single 
delayed oedema after the second injection of 
glucantime on the cheek. With systemic 
corticosteroids, oedema disappeared within three 
days.  
Cutaneous leishmaniasis healed leaving 
scars (n = 7) and/or post-inflammatory 
hyperpigmentation (n = 4).  
 
 
Discussion  
 
We identified nine cases of cutaneous 
leishmaniasis (Old World) in the last 16 years. All but 
one patient were infants, children and adolescents 
[8][9][10]. Five patients were from Aleppo, Syria, 
coming to Saxony as refugees. The most common 
sites affected, were head-and-neck region and hands 
not covered by clothes. In Aleppo and the surrounding 
northern area of Syria, L. major is the major pathogen 
[11]. L. infantum is the dominant species in Sicily [12]. 
In Germany 130 cases of leishmaniasis were 
registered from September 2000 and May 2007 with 
96 cutaneous and mucocutaneous disorders. Tourists 
represented the greatest group [13]. In Europe 
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EuroTravNet identified three hot spots for Leishmania 
infections in Europe, i.e. Spain, Malta, and Italy [14]. 
The largest outbreak of European leishmaniasis 
occurred in 2009 in Fuenlabrada, Spain, with 90 adult 
patients with either localised Leishmania 
lymphadenopathy or visceral leishmaniasis (81%) 
[15].  
In recent years, refugees and asylum seekers 
from the Middle East and North Africa have become 
more important in that manner. The official number of 
refugees registered in Saxony was 69,900 in 2015. In 
May 2017, around 25,000 refugees and asylum 
seekers officially lived in Saxony [16]. Outbreaks of 
cutaneous leishmaniasis have been reported from 
refugee camps in Lebanon and Turkey [17][18][19], 
but neither from Switzerland nor Germany 
[20][21][22].  
Another important source of infections are 
pets serving as a pathogen reservoir. Canine and 
feline infections from animals taken by tourists to 
endemic regions of the Mediterranean, and dogs and 
cats imported from there represent a risk factor for 
leishmaniasis spread in Central Europe [23].  
Treatment is dependent on clinical symptoms. 
Miltefosine, pentavalent antimonials, paromomycin 
and azole derivates are treatment options. Recently, 
case reports about successful photodynamic therapy 
have appeared, but systematic trials are missing 
[7][9]. In general, the safety of drug therapy is good. 
The adverse effects associated with miltefosine were 
vomiting, nausea, kinetosis, headache, diarrhea, and 
an increase in aminotransferases and creatinine. The 
most frequently reported clinical adverse effects of 
pentavalent antimonials and pentamidine were 
musculoskeletal pain, gastrointestinal problems, and 
headache. Electrocardiographic QTc interval 
prolongation and increase in liver and pancreatic 
enzymes were also seen [24]. We observed a facial 
edema after second injection with glucantime, that 
responded rapidly to systemic corticosteroids. The 
third injection was tolerated well. 
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